AUDIT MicroControls, Inc. Announces Linearity FLQ Anti-Mullerian Hormone for Roche Systems

Date: November 17, 2022


November 17, 2022 (Eatonton, GA) - AUDIT MicroControls, Inc. is pleased to announce the following new addition to our line of calibration verification/linearity and daily quality control products: Linearity FLQ Anti-Mullerian Hormone for Roche Systems. This product is intended to simulate human patient serum samples for purpose of determining linearity, calibration verification and verification of reportable range for Anti-Mullerian Hormone (AMH).

The Linearity FLQ Anti-Mullerian Hormone for Roche Systems, order number K896M-5, is assayed quality control material consisting of five levels of human serum. These five levels demonstrate a linear relationship to each other for Anti-Mullerian Hormone (AMH). This product has an open vial stability of 5 days when stored at 2-8°C.

AUDIT MicroControls provides Auditor QC, a free online, real-time data reduction program that offers Levey-Jennings charts and peer group analysis for daily quality control product users, as well as linearity graphs and peer group analysis. Report results are given immediately in an “inspector friendly format” and stored on the Auditor QC website for future reference.


AUDIT is the only total solution in linearity/calibration verification and daily quality control materials for clinical laboratories. AUDIT provides value to customers through high-quality products, easy-to-use data management tools, and unrivaled personalized service. Our partnership with Aalto Scientific, a leader in manufacturing and supply for more than forty years, enables us to offer significant cost-savings. This synergistic partnership means our customers benefit from a broad line of superior solutions that address the challenges faced by today’s labs. By better understanding our customers’ needs, AUDIT can find ways to make life in the lab a little easier.


For more information about AUDIT, please call (866) 25-AUDIT or visit To connect via social media, please visit,, and